General Evaluator, HCP Sales jobs in United States
cer-icon
Apply on Employer Site
company-logo

Hippocratic AI · 2 weeks ago

General Evaluator, HCP Sales

Hippocratic AI is a leading healthcare AI company focused on developing a safe, safety-focused Large Language Model for healthcare. The HCP Sales Evaluator role involves reviewing and assessing HCP-facing Voice AI sales interactions to ensure effective communication and compliance standards are met.

Artificial Intelligence (AI)Foundational AIGenerative AIHealth CareInformation Technology
check
Growth Opportunities

Responsibilities

Listen to and evaluate HCP-facing Voice AI sales calls, including prospecting, detailing, objection handling, and follow-up
Assess sales effectiveness, message clarity, professionalism, and appropriate compliance behavior
Identify weak messaging, poor objection handling, or inappropriate sales tactics
Score calls using defined rubrics and provide clear, actionable feedback
Flag potential performance or compliance risks

Qualification

Pharma sales experienceHCP communicationSales performance evaluationEnglish fluencyWritten communicationVerbal communicationJudgment callsCall review toolsDigital sales toolsVirtual detailing platforms

Required

2–5+ years of experience in pharma sales, medical device sales, or inside/virtual HCP-facing sales roles
Direct experience communicating with HCPs in a commercial sales context
Strong written and verbal communication skills
Ability to make clear, precise judgment calls when evaluating sales performance
Fluency in English
Reliable access to a computer and high-speed internet

Preferred

Experience reviewing recorded sales calls for quality or performance
Familiarity with virtual detailing platforms, CRMs, or call review tools
Experience selling specialty or complex therapies
Exposure to regulated commercial environments
Experience with digital or AI-enabled sales tools

Company

Hippocratic AI

twittertwittertwitter
company-logo
Hippocratic AI is a healthcare technology company that develops safety-focused large-language models for medical applications.

Funding

Current Stage
Growth Stage
Total Funding
$402M
Key Investors
AvenirKleiner PerkinsNVentures
2025-11-03Series C· $126M
2025-01-09Series B· $141M
2024-09-19Series A· $17M

Leadership Team

leader-logo
Alex Miller
Co-Founder
linkedin
leader-logo
Amy McCarthy
Chief Nursing Officer
linkedin
Company data provided by crunchbase